APOL1 and bacterial urinary tract infection: Most of the studies on the prevalence and clinical predictors of RPS following UTI were conducted in Europe, North America, Australia, and the Middle East and in Asia, with little or no data from sub-Saharan Africa, a region of the world where the APOL1 risk alleles are highly prevalent [62-73].